UPMC BEDFORD
1. Target Overview & Investment Thesis
UPMC BEDFORD is a 36-bed suburban community hospital in nan, PA with $49.9M in net patient revenue and a 1.7% operating margin. The hospital serves a payer mix of 30.7% Medicare, 0.7% Medicaid, and 68.7% commercial.
Thesis: Turnaround. Our ML models identify $3.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.7% to 9.1% (+736bps).
| Net Revenue HCRIS | $49.9M |
| Current EBITDA COMPUTED | $863K |
| Operating Margin COMPUTED | 1.7% |
| Occupancy HCRIS | 30.4% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 26.5% |
| Distress Probability ML | 51.1% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 1.7% places it above the state median. Among 77 size-comparable peers (18-72 beds), the median margin is 0.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (18-72), prioritizing same-state peers. 77 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| UPMC BEDFORD (Target) | PA | 36 | $49.9M | 1.7% |
| UPMC CARLISLE | PA | 72 | $165.0M | 19.5% |
| OSS ORTHOPAEDIC HOSPITAL | PA | 30 | $149.4M | -5.0% |
| WELLSPAN SURGERY AND REHAB HOS | PA | 25 | $120.2M | 2.8% |
| UPMC LITITZ | PA | 36 | $114.5M | 14.2% |
| MINERS MEMORIAL MEDICAL CENTER | PA | 49 | $107.7M | 12.4% |
| LVH-COORDINATED ALLENTOWN | PA | 20 | $89.6M | 2.3% |
| CHARLES COLE MEMORIAL HOSPITAL | PA | 25 | $88.1M | -9.0% |
| ST LUKES HOSPITAL-CARBON CAMPU | PA | 52 | $86.4M | 8.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $998K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $988K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $607K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $32K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $863K |
| + RCM Uplift | +$3.7M |
| Pro Forma EBITDA | $4.5M |
| Current Margin | 1.7% |
| Pro Forma Margin | 9.1% |
| WC Released (1x) | $1.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.3M | $42.4M | 31.97x | 100.0% |
| Base (11x exit) | 10.0x | 11.0x | $1.3M | $47.1M | 35.49x | 104.2% |
| Bull Case | 9.0x | 11.0x | $1.2M | $59.7M | 49.94x | 118.6% |
| Bull (12x exit) | 9.0x | 12.0x | $1.2M | $65.4M | 54.78x | 122.7% |
| Bear Case | 11.0x | 10.0x | $1.5M | $23.6M | 16.18x | 74.5% |
| Bear (11x exit) | 11.0x | 11.0x | $1.5M | $26.5M | 18.13x | 78.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 30.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 51.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 77 hospitals with 18-72 beds
- Same-state prioritization (n=78)
- Comp margins: P25=-13.6% / P50=0.1% / P75=8.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.